Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis

Intensive Care Medicine

Volumn 37, Issue 10, 2011, Pages 1605-1612

  Burghi, Gaston ^a   Lemiale, Virginie ^a   Seguin, Amélie ^a   Lambert, Jérôme ^a   Lacroix, Claire ^a   Canet, Emmanuel ^a   Moreau, Anne Sophie ^a   Ribaud, Patricia ^a   Schnell, David ^a   Mariotte, Eric ^a   Schlemmer, Benoît ^a   Azoulay, Elie ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Aspergillosis; ICU; Mechanical ventilation; Outcome

Indexed keywords

VORICONAZOLE;

ACUTE RESPIRATORY FAILURE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; BACTERIAL INFECTION; CONCURRENT INFECTION; CONTROLLED STUDY; FEMALE; FUNGUS ISOLATION; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; INTENSIVE CARE; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPENIA; RETROSPECTIVE STUDY; STEROID THERAPY; SURVIVAL; THORAX RADIOGRAPHY;

ADULT; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80054852326     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-011-2344-8     Document Type: Article

References (39)

1. Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A, Yang K, Meignin V, Ciroldi M, Le Gall JR, Tazi A, Schlemmer B (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360-370 (Pubitemid 39545182)
2. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265-273
3. Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R (2008) Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 47:1176-1184
4. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091-1100
5. Baddley JW (2010) Clinical risk factors for invasive aspergillosis. Med Mycol 49(supp1):S7-S12
6. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 34:7-14 (Pubitemid 33152659)
7. Marr KA, Carter R, Boeckh M (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 100:4358-4366 (Pubitemid 35429674)
8. Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger K, Pigneux A, Cornely OA, Ullmann AJ, Bofarull RM, de la Camara R, Weisser M, Liakopoulou E, Abecasis M, Heussel CP, Pineau M, Ljungman P, Einsele H (2010) Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: Results of the VOSIFI study. Haematologica 95:1762-1768
9. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348-359 (Pubitemid 46148777)
10. Illmer T, Babatz J, Pursche S, Stolzel F, Schuler U, Schaich M, Ehninger G (2011) Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia. Mycoses 54:e143-e147
11. Leventakos K, Lewis RE, Kontoyiannis DP (2010) Fungal infections in leukemia patients: How do we prevent and treat them? Clin Infect Dis 50:405-415
12. Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356:335-347 (Pubitemid 46148776)
13. Vehreschild JJ, Bohme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA (2007) A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML). J Infect 55:445-449 (Pubitemid 47628350)
14. Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808-822 (Pubitemid 43781361)
15. Azoulay E, de Miranda S, Bele N, Schlemmer B (2008) Diagnostic strategy for acute respiratory failure in patients with haematological malignancy. Rev Mal Respir 25:433-449 (Pubitemid 351723740)
16. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, Vincent F, Gruson D, Bruneel F, Epinette-Branche G, Lafabrie A, Hamidfar-Roy R, Cracco C, Renard B, Tonnelier JM, Blot F, Chevret S, Schlemmer B (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: Randomized controlled trial. Am J Respir Crit Care Med 182:1038-1046
17. Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B (2001) Improved survival in cancer patients requiring mechanical ventilatory support: Impact of noninvasive mechanical ventilatory support. Crit Care Med 29:519-525 (Pubitemid 32225292)
18. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481-487 (Pubitemid 32164899)
19. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408-415 (Pubitemid 34851833)
20. Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, Schwartz S, Ullmann AJ, Meert L, Paesmans M, Marchetti O, Akan H, Ameye L, Shivaprakash M, Viscoli C (2010) Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: An European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant 45:1227-1233
21. Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Severino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ (2010) Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. Eur J Clin Microbiol Infect Dis 29:1387-1394
22. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr K, Munoz P, Odds FC, Perfect J, Restrepo A, Ruhnke M, Segal BH, Sobel J, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Disease Mycoses Study Groups (EORTC/MSG) Consensus Group. CID 46:1813
23. Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Ame S, Lutz P, Dufour P, Bergerat JP, Candolfi E (2002) Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20:1898-1906 (Pubitemid 34273282)
24. Caillot D, Latrabe V, Thiebaut A, Herbrecht R, De Botton S, Pigneux A, Monchecourt F, Mahi L, Alfandari S, Couaillier JF (2010) Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: An useful tool for diagnosis and assessment of outcome in clinical trials. Eur J Radiol 74:e172-e175
25. Kawel N, Schorer GM, Desbiolles L, Seifert B, Marincek B, Boehm T (2011) Discrimination between invasive pulmonary aspergillosis and pulmonary lymphoma using CT. Eur J Radiol 77:417-425
26. Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH (2007) Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign. Clin Infect Dis 44:373-379 (Pubitemid 46147619)
27. van de Beek D, Patel R, Campeau NG, Badley A, Parisi JE, Rabinstein AA, Manno EM, Wijdicks EF (2008) Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients. Neurology 70:2411-2413
28. Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E, Arnulf B, Socie G, Ribaud P, Tazi A (2010) Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 137:410-415
29. Wingard JR, Ribaud P, Schlamm HT, Herbrecht R (2008) Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 112:2309-2312 (Pubitemid 351628643)
30. Thiery G, Azoulay E, Darmon M, Ciroldi M, De Miranda S, Levy V, Fieux F, Moreau D, Le Gall JR, Schlemmer B (2005) Outcome of cancer patients considered for intensive care unit admission: A hospital-wide prospective study. J Clin Oncol 23:4406-4413 (Pubitemid 46207015)
31. Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, Schlemmer B, Nitenberg G, Buzyn A, Arnaud P, Socie G, Mira JP (2006) Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol 24:643-649 (Pubitemid 46630428)
32. Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW (2005) Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: Interim results of a prospective multicenter surveillance program. Med Mycol 43(Suppl 1): S49-S58 (Pubitemid 41038548)
33. Ribaud P, Chastang C, Latge JP, Baffroy-Lafitte L, Parquet N, Devergie A, Esperou H, Selimi F, Rocha V, Esperou H, Selimi F, Rocha V, Derouin F, Socie G, Gluckman E (1999) Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 28:322-330 (Pubitemid 29241222)
34. Gallien S, Fournier S, Porcher R, Bottero J, Ribaud P, Sulahian A, Socie G, Molina JM (2008) Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: A review of 34 cases. Infection 36:533-538
35. Escher M, Perneger TV, Chevrolet JC (2004) National questionnaire survey on what influences doctors' decisions about admission to intensive care. BMJ 329:425
36. Nucci M, Nouer SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E (2010) Probable invasive Aspergillosis without prespecified radiologic findings: Proposal for inclusion of a new category of Aspergillosis and implications for studying novel therapies. Clin Infect Dis 51:1273-1280
37. Maertens J, Buve K, Theunissen K, Meersseman W, Verbeken E, Verhoef G, Van Eldere J, Lagrou K (2009) Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 115:355-362
38. Sharma S, Nadrous HF, Peters SG, Tefferi A, Litzow MR, Aubry MC, Afessa B (2005) Pulmonary complications in adult blood and marrow transplant recipients: Autopsy findings. Chest 128:1385-1392 (Pubitemid 41324422)
39. Adda M, Coquet I, Darmon M, Thiery G, Schlemmer B, Azoulay E (2008) Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 36:2766-2772